Intravitreal Injection of Expansile Perfluoropropane (C3F8) for the Treatment of Vitreomacular Traction

Intravitreal C3F8 injection could offer a minimally invasive alternative to PPV in patients with symptomatic and persistent vitreomacular traction. It appears particularly effective in eyes with less extensive vitreomacular traction and low vitreous face reflectivity on SD OCT. Further studies are warranted.